. Surgical resection is an effective treatment for hepatocellular carcinoma (HCC) at an early stage. A large population of HCC patients is diagnosed with advanced disease and oxaliplatin (OXA)-based chemotherapy is considered to be an important treatment choice for advanced-stage HCC. However, recurrence and metastasis after surgery, as well as poor chemosensitivity persist as a major barrier to successful chemotherapy in HCC.
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Our previous study found that HCC cells with EMT phenotype acquired OXA-resistance 8 . Since that, EMT suppression may be synergistic with conventional chemotherapy to improve HCC prognosis.
Neferine (CAS No.: 2292-16-2) is a major bisbenzylisoquinoline alkaloid derived from the seed embryo of lotus (Nelumbo nucifera, a traditional medicinal plant), demonstrating the nontoxic nature of it 9 . Previous studies had shown that Neferine exerted extensive cardio-protective effects, such as anti-hypertensive, anti-arrhythmic 10 , anti-agglutinating, anti-thrombotic 11 , cholinesterase inhibition 12 , as well as its anti-diabetes functions 13 . Importantly, Neferine was suggested to have antitumor effects and sensitized the cancer cells to chemotherapeutic agents. The multidrug resistance was documented to be reversed in human gastric carcinoma cells by Neferine 14 . Neferine inhibited lung cancer cells growth 15, 16 and potentiated anti-cancer effect on lung cancer when combined with doxorubicin 17 . Meanwhile, Neferine could inhibit the proliferation of HCC cells 18, 19 and osteosarcoma cells 20 . Neferine was also reported to induce autophagy of ovarian cancer cells 21 . However, the effects of Neferine on HCC invasion and chemosensitivity need to be elucidated.
Based on the existed evidence and understanding, the present study aims to prove our hypothesis that Neferine may have some anti-tumor effects on the invasion and chemosensitivity through EMT regulation in HCC cells.
Results
The effects of Neferine on cells viability in HCC and normal hepatic cells. L02 OXA-inhibited HCC growth was potentiated by Neferine. The dose-dependent viability of HCC cells was firstly measured in the group of OXA treatment alone for 48 hrs to determine its IC 50 , which was 5.99 ± 0.35 μ M for HepG2 and 4.81 ± 0.39 μ M for Bel-7402. OXA at 5 μ M, which was the nearest concentration to the IC 50 values of OXA treatment alone, was then chosen for further co-treatment combined with Neferine.
The cells were subsequently treated with OXA at different concentrations combined with Neferine at 10 μ M for 48 hrs. Neferine significantly improved OXA-induced cytotoxicity in HepG2 and Bel-7402 cells. As compared with the control group without any treatment, 5 μ M OXA induced 45.91 ± 1.86% growth inhibitions in HepG2, which was considerably increased to 62.35 ± 1.35% in co-treatment group of OXA + Neferine (p < 0.01). In Bel-7402 cells, the growth inhibition rate in OXA treatment group was significantly improved in the combined treatment group of 5 μ M OXA and 10 μ M Neferine (47.23 ± 3.27% vs. 64.22 ± 2.86%, p < 0.05, Fig. 1b) . Meanwhile, Neferine obviously reduced the IC 50 values of OXA from 5.99 ± 0.35 μ M to 3.15 ± 0.32 μ M for HepG2, from 4.81 ± 0.39 μ M to 2.29 ± 0.20 μ M for Bel-7402 cells (Fig. 1c , p < 0.01, respectively). In colony formation assays, the group of OXA + Neferine had a significantly decreased colony amounts than the OXA treatment group (p < 0.01, Fig. 1d ). These results indicated that Neferine significantly increased the chemosensitivity of HCC cells to OXA, implying a synergistic effect between OXA and Neferine. To quantitatively analyze the interactions between Neferine and OXA, an arithmetic method of isobologram indicated a synergistic effect between Neferine and OXA (Fig. 1e) .
Neferine promoted OXA-induced apoptosis of HCC cells. The flow cytometry results exhibited that
Neferine at the concentration of 10 μ M did not have significant apoptosis induction ability. In Neferine treatment and control groups, the apoptosis rates were 4.16% ± 0.33 and 4.75% ± 0.28 for HepG2 cells (p = 0.21), 3.90% ± 0.41 and 4.0% ± 0.31 (p = 0.87) for Bel-7402 cells, respectively. The apoptosis rates of HepG2 cells were 16.42% ± 0.48 induced by OXA and 34.97 ± 1.0% induced by OXA combined with Neferine (OXA vs. OXA + Neferine, p < 0.001). Consistently, combination regimens showed higher apoptosis rate of Bel-7402 cells as compared with single OXA agent (23.24 ± 0.76% vs. 43.0 ± 0.72%, OXA vs. OXA + Neferine, p < 0.001, Fig. 2a ). Western blot revealed that the expression of anti-apoptotic protein Bcl-2 was decreased significantly but that of pro-apoptotic proteins Bax and active caspase-3 was increased significantly in the co-treatment group, as compared with that in individual agent (either OXA or Neferine) treatment group (Fig. 2b) .
Establishment of TGF-β1-induced EMT model in HCC cells. Since EMT played an important role in invasion and chemoresistance of cancer cells, we explored whether EMT and invasion capacity were regulated by Neferine in HCC cells. We found that Neferine alone inhibited cells migration/invasion abilities ( Supplementary Fig. S1 , p < 0.01, respectively), and promoted HCC epithelial cells HepG2 and Bel-7402 to more epithelial phenotype by increasing E-cadherine expression and decreasing Vimentin/N-cadherin/Snail expression ( Supplementary Fig. S2 ). We next established a model of TGF-β 1-induced EMT in HCC cells in time-and dose-dependent manners to further investigate the association between EMT progress and Neferine-promoted chemosensitivity of HCC cell. HepG2 cells and Bel-7402 cells were treated with different concentrations (5 ng/ml, 10 ng/ml, 20 ng/ml) of TGF-β 1 for 24 hrs and 48 hrs. qRT-PCR and Western blot revealed that TGF-β 1 at the dose of 10 ng/ml for 48 hrs induced obvious EMT of HCC cells with decreased expression level of E-cadherin but increased expression level of N-cadherin and Vimentin as compared with the untreated cells (Fig. 3a,b) . The expression of Snail, a transcription factor of EMT, rapidly increased at 24 hrs with the administration of TGF-β 1 (Fig. 3a,b) . Being stimulated with 10 ng/ml TGF-β 1 for 48 hrs, cells gradually elongated and dispersed. The administration of TGF-β 1 changed cells morphology from pebble-like epithelial to spindle-like mesenchymal and pseudopodium stretching after 72 hrs (Fig. 3c) . Taken together, 10 ng/ml TGF-β 1 for 48 hrs was chosen to induce HCC EMT in further experiments.
Neferine reversed TGF-β1-induced EMT phenotype in HCC cells. Due to the important roles of EMT in invasion and chemoresistance of cancer cells, we further explored whether EMT was regulated by Neferine in HCC cells. qRT-PCR, Western blot and immunofluorescence staining were respectively applied to detect the expression levels and co-localization of EMT biomarkers in Neferine and/or OXA-treated HCC cells with the administration of 10 ng/ml TGF-β 1. TGF-β 1 induced EMT phenotype as compared to the control groups, as well as the same phenomenon occurred in TGF-β 1 co-treatment with OXA groups. Comparing to the TGF-β 1 groups, Neferine treatment alone and combined with OXA groups resulted in a down-regulated mRNA and protein expression of Vimentin and N-cadherin, concomitant with an up-regulated expression of E-cadherin in TGF-β 1-treated HCC cells. Moreover, mRNA and protein expression of transcription factor Snail, which is critical for EMT induction, was significantly decreased in Neferine treatment and co-treatment with OXA groups. Expression of Slug, another EMT transcription factor, was decreased in Neferine-treated HepG2 but not in Bel-7402 cells. The expression of the other EMT-related transcription factors of Twist and Zeb1 was not significantly regulated by Neferine treatment (Fig. 4a,b ). Cellular immunofluorescence labeled by E-cadherin and Vimentin antibodies confirmed the suppression effects of Neferine on TGF-β 1-induced EMT in HepG2 and Bel-7402 cells (Fig. 4c ).
Neferine inhibited TGF-β1-promoted migration and invasion abilities of HCC cells. EMT is
involved in many aspects of cellular behaviors, such as the mobility of cancer cells. Herein, we found the suppression function of Neferine on TGF-β 1-induced EMT, so that we further explored the effects of Neferine on migration and invasion abilities of TGF-β 1-treated HCC cells. Wound healing assays showed that the migration ability of HCC cells was significantly promoted by TGF-β 1 treatment (Fig. 4d , Control vs. TGF-β 1, p < 0.01, respectively) but repressed by Neferine treatment in TGF-β 1-treated HCC cells (Fig. 4d , TGF-β 1 + Neferine vs. TGF-β 1, p < 0.001, respectively). In the results of transwell tests, TGF-β 1 groups enhanced obviously invasion ability as compared with untreated control groups (Fig. 4e , Control vs. TGF-β 1, p < 0.01, respectively) while Neferine treatment in TGF-β 1-treated HCC cells displayed a significantly lower invasion capacity than the groups consisting of TGF-β 1-treated HepG2 and Bel-7402 cells (Fig. 4e , TGF-β 1 + Neferine vs. TGF-β 1, p < 0.001, respectively). To confirm the EMT regulation of Neferine, the HCC cells were pre-treated with Neferine for 48 hrs (Neferine + TGF-β 1 groups) before the administration of TGF-β 1 in wound healing and transwell invasion assays. Interestingly, treatment with TGF-β 1 cancelled the suppressed migration and invasion abilities of Neferine-pretreated HCC cells (Fig. 4d ,e, Neferine + TGF-β 1 vs. TGF-β 1 + Neferine, p < 0.01, respectively).
Knockdown of Snail inhibited EMT phenotype and migration, but enhanced OXA sensitivity.
To determine the roles of Snail in HCC cells' migration and chemosensitivity, we knocked down the expression of Snail with siRNA in HCC cells and performed further study. The expression changes of EMT markers in HepG2 and Bel-7402 cells were assayed by qRT-PCR and Western blot. Comparing to the si-control groups, Snail knockdown significantly decreased the expression levels of mesenchymal markers of N-cadherin and Vimentin, and increased the expression levels of epithelial marker of E-cadherin (Fig. 5a ). Wound healing and transwell assays indicated that knockdown of Snail significantly inhibited HCC cells' migration and invasion abilities as compared to the si-control groups (Fig. 5b,c . p < 0.01, respectively). Si-Snail groups enhanced the sensitivity of HCC cells against OXA as compared with the si-control groups by decreasing the IC 50 values of OXA from 6.844 ± 1.108 μ M to 3.411 ± 0.375 μ M for HepG2 and from 5.339 ± 0.338 μ M to 2.340 ± 0.304 μ M for Bel-7402 (Fig. 5d , p < 0.05, respectively), implying the correlation of Snail and chemosensitivity.
Snail overexpression induced EMT and eliminated migration suppression and OXA sensitivity regulated by Neferine in HCC cells. The above results exhibited the suppression of Snail expression by
Neferine and the association of Snail with migration and chemosensitivity in HCC cells. We further investigated the functions of Snail overexpression on EMT, Neferine-suppressed migration and Neferine-promoted OXA sensitivity in HCC cells. Snail overexpression by Snail plasmid (pcDNA3.1-Snail) transfection induced an obvious EMT progress, which was recognized by decreased E-cadherin expression and increased Vimentin/N-cadherin expression (Supplementary Figure S3a-c) . Neferine treatment caused obvious migration and invasion suppression in the blank vector transfection groups (Fig. 6a,b , pcDNA3.1-NC vs. pcDNA3.1-NC + Neferine, p < 0.05, respectively). Consequently, EMT induced by Snail overexpression significantly enhanced the migratory and invasive capabilities of Snail-transfected HCC cells as compared to pcDNA3.1-NC groups (Fig. 6a,b , p < 0.001, respectively). Migratory and invasive capabilities were significantly enhanced in pcDNA3.1-Snail groups which were pre-treated with Neferine for 48 hrs than the control groups transfected with the blank vector (pcD-NA3.1-NC) which were pre-treated with Neferine (Fig. 6a,b , p < 0.001, respectively), implying that overexpression of Snail eliminated migration suppression by Neferine. Based on the chemoresistance induced by EMT, Snail transfection significantly attenuated OXA sensitization by Neferine in HepG2 and Bel-7402 cells. CCK-8 assays Supplementary Fig. S5. (c) Representative double indicated that pcDNA3.1-Snail groups had significantly decreased OXA sensitivity than pcDNA3.1-NC groups (Fig. 6c, p < 0.01, respectively) .
TGF-β1 attenuated OXA sensitization by Neferine. To further confirm the roles of EMT regulation in chemosensitivity by Neferine, we examined cells viability treated with Neferine and OXA and TGF-β 1 by CCK-8 assays. TGF-β 1 groups exhibited higher cells viability than the groups with combined treatment of Neferine and OXA without TGF-β 1, suggesting TGF-β 1 attenuated OXA sensitization by Neferine (Fig. 6d , p < 0.001, respectively).
Neferine increased OXA sensitivity via EMT inhibition in xenograft nude mice. We established subcutaneous xenograft tumor models to verify the effects of Neferine on EMT-regulated OXA sensitivity of HCC in vivo. As shown in Fig. 7a , HepG2 cell-derived tumors at the implantation sites treated with OXA alone were statistically larger than that treated with OXA and Neferine (0.73 ± 0.01 cm 3 vs. 0.12 ± 0.03 cm 3 , p < 0.01). Consistently, Bel-7402 cell-derived tumors in OXA treatment group grew more rapidly than that in OXA/ Neferine co-treatment group (0.64 ± 0.12 cm 3 vs. 0.15 ± 0.05 cm 3 , p < 0.05). The mean MMPs activities, which were involved in EMT and represented by the fluorescence intensities, in OXA treatment groups were significantly higher than that in OXA/Neferine co-treatment groups (HepG2: 32.31 ± 2.27 vs. 15.95 ± 1.37, p < 0.01; Bel-7402: 25.72 ± 1.13 vs. 13.79 ± 1.83, p < 0.01, Fig. 7b ). Expression of cell proliferation index (Ki-67) and EMT biomarkers of E-cadherin/Vimentin, which was detected by qRT-PCR and IHC, indicated that Neferine treatment significantly depressed HCC EMT phenotype and cell proliferation in xenograft tumor (Fig. 7c,d ).
Discussion
Over years, a great deal of efforts has been taken to increase chemosensitivity in HCC patients. However, owing to little and limited understanding of chemoresistant mechanisms, the prognosis of HCC remains poor. New therapeutic strategies which potentiate chemotherapeutic sensitivity safely provide a promising approach for effective HCC treatment. The present study indicated that co-administration of Neferine, a natural component of Nelumbo nucifera, could enhance OXA chemosensitivity in HCC.
Regarding to the anti-tumor effects of Neferine against HCC, Paramasivan et al. 18 reported that Neferine at the dose of 10 μ M exhibited obviously cytotoxicity by inducing reactive oxygen species mediated intrinsic pathway of HepG2 apoptosis. However, we did not find any significant effect of Neferine at the concentration of 10 μ M on the proliferation of both HepG2 and Bel-7402 cells. Consistent to our finding, Yoon 19 provided evidences that Neferine at the concentration of 20 μ M exhibited significant cytotoxicity against Hep3B cells via ER stress and autophagy induction, while 10 μ M Neferine showed no distinct effect. Even at the dose of 20 μ M, Neferine, which was extracted by the researchers themselves, did not affect the growth of Sk-Hep1 cells and primary normal hepatocytes of THLE-3. Different liver (cancer) cells may have diverse tolerance to Neferine. Meanwhile, the purity decided by extraction methods may have significant influences on the stability and antitumor activity of Neferine.
In general, a variety of mechanisms contributes to drug resistance, which occurs in almost all chemotherapeutic agents and results in low response and tumor refractoriness in HCC treatment. Accumulated evidences indicate that EMT is associated with proliferation, invasion/migration, metastasis, and chemoresistance in human cancer 22, 23 . EMT is a dynamic process which can be triggered by many molecules including transforming growth factor-β (TGF-β ), Notch, Wnt, tumor necrosis factor-α (TNF-α ), and other cytokines 24, 25 . MMPs contribute prominently to their signals in micro-environment via degrading structural components of ECM and promote invadopodia formation to activate EMT process, permitting tumor invasion and metastasis [26] [27] [28] . Indeed, EMT plays an important role in invasion and chemoresistance associated at molecular and phenotypic levels 7, 29, 30 . It was reported that tumor cells acquired EMT phenotype reduced susceptibility to chemotherapy by increasing apoptotic resistance, upregulation of chemoresistance and drug metabolizing genes including drug transporters aldehyde dehydrogenases (ALDHs), cytochrome P450s, and glutathione-metabolism-related enzymes 6 . EMT induced by transcription factor of Snail was found to attenuate cell cycle through blocking the G1/S transition due to downregulation of Cyclin D2 transcription 31 . Under this condition, decreased activities of caspase 3/8 in Snail-expressing cells and high activities of MEK/Erk and PI3K/Akt signaling led to the upregulation of pro-apoptosis Bcl-2 family 32 . Thus, Snail conferred resistance to cell death, suggesting that EMT-induction is prone to resistance to apoptosis. It has also been observed that restoring E-cadherin expression increased immunofluorescence staining for expression and co-localization of E-cadherin and Vimentin in TGF-β 1-treated HCC cells treated with Neferine and/or OXA. (Original magnification: × 400). sensitivity to epidermal growth factor receptor inhibitors in lung cancer cells, while mesenchymal-like cells were resistance to drug treatment 33 . Meanwhile, Snail suppressed TGF-β -induced apoptosis and was sufficient to trigger EMT in hepatocytes 34 . EMT inhibition could be a useful strategy to cause a loss of anti-apoptotic signal and/or trigger apoptotic responses to sensitize cancer cells to chemotherapy. Accompanying with caspase-3 activation, upregulating of Bax and downregulating Bcl-2 expression, Neferine exerted a promotion of OXA-induced HCC apoptosis through EMT inhibition in this study. Moreover, EMT-generated properties of cancer stem cells (CSCs) are important reasons contributing to chemoresistance in human cancers 35, 36 . EMT facilitates the generation of CSCs with the mesenchymal traits which are required for dissemination and chemoresistance 37 . The cells with CSC phenotype (CD44high, CD24low) in breast cancer were found to be resistant to neoadjuvant chemotherapy 38 . Furthermore, Snail was associated with CSCs-like traits acquisition and mediated cell survival in ovarian cancer effectively 39 . PI3K pathway, which was confirmed to be activated in Snail-expressing cells 31 , was directly linked to CSCs expansion and maintenance via promoting the proliferation of CSCs in breast cancer 40 and prostate cancer 41 . Targeting CSCs therapy therapeutically seems to overcome drug resistance. Antibiotic salinomycin could kill breast CSCs preferentially and 42 . We demonstrated that Snail overexpression induced EMT and eliminated OXA sensitization effects of Neferine in HCC. However, the roles of EMT-elicited HCC CSCs in OXA sensitivity promoted by Neferine needs to be further clarified.
In conclusion, Neferine significantly suppressed EMT so as to inhibit cell mobility but increased OXA sensitivity via Snail signaling in HCC. Our findings suggest that Neferine may be a potent OXA sensitizer in HCC to improve the patients' chemotherapy response.
Methods
Chemicals. Neferine Immunofluorescence staining. Fixed treated cells with 4% paraformaldehyde for 25 mins and permeabilized with 0.1% Triton X-100 for 10 mins. Blocked with 2% bovine serum albumin (BSA) for 30 mins at 37 °C and followed by the primary antibody against E-cadherin (1:200, Abcam, Cambridge, UK) and Vimentin (1:500, Abcam) at 4 °C overnight. The cells were subsequently incubated with the corresponding Alexa Fluor 546 or Alexa 488-conjugated secondary antibody for 1 hr at room temperature. The nuclei were stained with DAPI for 3 mins. The images were captured using a DMI-4000B inverted fluorescence microscopy (Leica).
Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Total
RNA was isolated using Trizol Reagent (Invitrogen) and the cDNA was synthetized using the PrimeScript ™ Kit (TaKaRa Bio Inc., Otsu, Japan) following the manufacturer's instructions. qRT-PCR was performed in triplicate using SYBR Green fluorescent-based assay (TaKaRa Bio Inc.) on a ViiA TM 7 RT-PCR system (Applied Biosystems, Carlsbad, CA). The primers for real-time PCR were listed as follows: E-cadherin Forward: 5′ -TACGCCTGGGACTCCACCTA-3′ , Reverse: 5′ -CCAGAAACGGAGGCCTGAT-3′ ; Vimentin Forward: 5′ -TGTGGATGT TTCCAAGCCTGAC-3′ , Reverse: 5′ -GAGTGGGTATCAACCAGAGGGAG-3′ ; N-cadherin Forward: 5′ -CCACGCCGAGCCCCAGTATC-3′ , Reverse: 5′ -CCCCCA GTCGTTCAGGTAATCA-3′ ; Snail Forward: 5′ -CACTATGCCGCGCTCTTTC-3′ , Reverse: 5′ -GCTGGAAGGTAAACTCl′ GGATTAGA-3′ ; GAPDH Forward: 5′ -CGG AGTCAACGGATTTGGTCGTAT-3′ , Reverse: 5′ -AGCCTTCTCCATGGTGGTGA AGAC-3′ ; Slug Forward: 5′ -GGGCTCAGTTCGTAAAGG-3′ , Reverse: 5′ -GAGGAGGTGTCAGATGGA-3′ ; Twist Forward: 5′ -TTTACATCCGATTTACTGC-3′ , Reverse: 5′ -CCTAATGCTTTCCCTCAT-3′ ; Zeb1 Forward: 5′ -AAGTGGCGGTAGATGGTA-3′ , Reverse: 5′ -TTGTAGCGACTGGATTTT-3′ . Relative mRNA expression levels were calculated by the 2 −ΔCt [Δ Ct = Ct (targeting gene)-Ct (GAPDH)] method and were normalized to the internal control of GAPDH. Western blot. Total protein was extracted in RIPA lysis buffer, separated by SDS-PAGE and then transferred onto PVDF membrane (Millipore, Bedford, MA). The membranes were blocked in TBST containing 5% skim milk at 37 °C for 2 hrs and respectively incubated with the primary antibodies at 4 °C overnight against Bcl-2 (1:200), Bax (1:1000), active caspase-3 (1:200), Vimentin (1:1000), E-cadherin (1:5000), Snail (1:500), Slug (1:1000), Twist (1:500), Zeb1 (1:1000), GAPDH (1:5000, Abcam), and N-cadherin (1:1000, Cell Signaling Technologies, Beverly, MA), followed by an incubation with HRP-conjugated secondary antibody (1:5000, Abcam) for 1 hr at 37 °C. Employing the enhanced chemiluminescence kit (Millipore), the bands were automatically visualized using a ChemiDoc XRS + system (Bio-Rad, Hercules, CA) and quantitatively analyzed with Image Lab software (Bio-Rad). GAPDH expression was used as the internal control to normalize the sample loading amounts.
Xenograft model. To 
